Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis
- PMID: 20848493
- PMCID: PMC2991605
- DOI: 10.1002/ibd.21320
Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis
Abstract
Background: Bromelain, a mixture of proteolytic enzymes typically derived from pineapple stem, decreases production of proinflammatory cytokines and leukocyte homing to sites of inflammation. We previously showed that short-term oral treatment with bromelain purified from pineapple stem decreased the severity of colonic inflammation in C57BL/6 Il10(-/-) mice with chronic colitis. Since fresh pineapple fruit contains similar bromelain enzymes but at different proportions, this study aimed to determine whether long-term dietary supplementation with pineapple (supplied as juice) could decrease colon inflammation and neoplasia in Il10(-/-) mice with chronic colitis as compared with bromelain derived from stem.
Methods: Colitis was triggered in Il10(-/-) mice by exposure to the non-steroidal anti-inflammatory drug piroxicam. Mice with colitis were supplemented with fresh vs. boiled pineapple juice or bromelain purified from stem for up to 6 months.
Results: Experimental mice readily consumed fresh pineapple juice at a level that generated mean stool proteolytic activities equivalent to 14 mg bromelain purified from stem, while control mice received boiled juice with inactive enzymes. Survival was increased in the group supplemented with fresh rather than boiled juice (P = 0.01). Mice that received fresh juice also had decreased histologic colon inflammation scores and a lower incidence of inflammation-associated colonic neoplasia (35% versus 66%; P < 0.02), with fewer neoplastic lesions/colon (P = 0.05). Flow cytometric analysis of murine splenocytes exposed to fresh pineapple juice in vitro demonstrated proteolytic removal of cell surface molecules that can affect leukocyte trafficking and activation.
Conclusions: These results demonstrate that long-term dietary supplementation with fresh or unpasteurized frozen pineapple juice with proteolytically active bromelain enzymes is safe and decreases inflammation severity and the incidence and multiplicity of inflammation-associated colonic neoplasia in this commonly used murine model of inflammatory bowel disease.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
Figures
Similar articles
-
Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.Clin Immunol. 2005 Aug;116(2):135-42. doi: 10.1016/j.clim.2005.04.011. Clin Immunol. 2005. PMID: 15936249
-
A comparative study of the effects of bromelain and fresh pineapple juice on the early phase of healing in acute crush achilles tendon injury.J Med Food. 2011 Apr;14(4):348-52. doi: 10.1089/jmf.2010.0078. Epub 2011 Jan 23. J Med Food. 2011. PMID: 21254908
-
Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice.Int Immunopharmacol. 2004 Feb;4(2):255-64. doi: 10.1016/j.intimp.2003.12.010. Int Immunopharmacol. 2004. PMID: 14996417
-
Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms.Nutrients. 2024 Jun 28;16(13):2060. doi: 10.3390/nu16132060. Nutrients. 2024. PMID: 38999808 Free PMC article. Review.
-
Bromelain: from production to commercialisation.J Sci Food Agric. 2017 Mar;97(5):1386-1395. doi: 10.1002/jsfa.8122. Epub 2016 Nov 29. J Sci Food Agric. 2017. PMID: 27790704 Review.
Cited by
-
Anticancer properties of bromelain: State-of-the-art and recent trends.Front Oncol. 2023 Jan 9;12:1068778. doi: 10.3389/fonc.2022.1068778. eCollection 2022. Front Oncol. 2023. PMID: 36698404 Free PMC article. Review.
-
Beneficial Properties of Bromelain.Nutrients. 2021 Nov 29;13(12):4313. doi: 10.3390/nu13124313. Nutrients. 2021. PMID: 34959865 Free PMC article. Review.
-
Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary.Foods. 2021 Sep 23;10(10):2249. doi: 10.3390/foods10102249. Foods. 2021. PMID: 34681298 Free PMC article. Review.
-
Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis.PLoS One. 2020 Sep 17;15(9):e0239295. doi: 10.1371/journal.pone.0239295. eCollection 2020. PLoS One. 2020. PMID: 32941525 Free PMC article.
-
Oral administration with a traditional fermented multi-fruit beverage modulates non-specific and antigen-specific immune responses in BALB/c mice.PLoS One. 2020 May 11;15(5):e0233047. doi: 10.1371/journal.pone.0233047. eCollection 2020. PLoS One. 2020. PMID: 32392269 Free PMC article.
References
-
- Hale LP, Singer KH, Haynes BF. CD44 antibody against In(Lu)-related p80, lymphocyte homing receptor molecule, inhibits the binding of human erythrocytes to T cells. J. Immunol. 1989;143:3944–3948. - PubMed
-
- Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol. 1992;149:3809–3816. - PubMed
-
- Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol. 2002;104:183–190. - PubMed
-
- Hale LP, Greer PK, Trinh CT, Gottfried MR. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol. 2005;116:135–142. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical